Expert opinion: assessing cardiac risk prior to use of triptans.

@article{Evans2000ExpertOA,
  title={Expert opinion: assessing cardiac risk prior to use of triptans.},
  author={Randolph W. Evans and Vincent S. Martin},
  journal={Headache},
  year={2000},
  volume={40 7},
  pages={599-602}
}
CLINICAL HISTORY This 60-year-old woman has had a history of severe migraines without aura since she was 25 years old. The attacks now occur once every 3 weeks or less, lasting up to a week without treatment. Sumatriptan, 6 mg, administered subcutaneously (SQ) completely relieves the headache and zolmitriptan, 5 mg, decreases the headaches to a dull level. Sumatriptan, 50 mg, administered orally, a sumatriptan 20-mg nasal spray, and rizatriptan, 10 mg, do not help. There is no history of… CONTINUE READING

Similar Papers

Loading similar papers…